Trishula Therapeutics

0 followers

‌

Trishula Therapeutics is a clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody.

Industries

Headquarters

Stage

Employees

Links

Org chart

President & CEO

Anil Singhal

Collapse

VP, Head of Immunology & Translational Sciences

VP, CMC

Head of Clinical Operations

Chief Medical Officer

Sr Clinical Data Manager

Senior Director Project Management

4 members

4 members

1 members

Coherus BioSciences

5 followers

BioMarin Pharmaceutical

20 followers

Adaptive Biotechnologies

11 followers

Eikon Therapeutics

1 follower

Dragonfly Therapeutics

1 follower

Discover companies